Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sanegre, Sabina"'
Autor:
Frago, Susana, Nicholls, Ryan D., Strickland, Madeleine, Hughes, Jennifer, Williams, Christopher, Garner, Lee, Surakhy, Mirvat, Maclean, Rory, Rezgui, Dellel, Prince, Stuart N., Zaccheo, Oliver J., Ebner, Daniel, Sanegre, Sabina, Yu, Sheng, Buffa, Francesca M., Crump, Matthew P., Hassan, Andrew Bassim
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2016 May . 113(20), E2766-E2775.
Externí odkaz:
https://www.jstor.org/stable/26469928
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sanegre, Sabina, Eritja, Núria, de Andrea, Carlos, Diaz-Martin, Juan, Diaz-Lagares, Ángel, Jácome, María Amalia, Salguero-Aranda, Carmen, García Ros, David, Davidson, Ben, Lopez, Rafel, Melero, Ignacio, Navarro, Samuel, Ramon y Cajal, Santiago, de Alava, Enrique, Matias-Guiu, Xavier, Noguera, Rosa
Publikováno v:
Sanegre, Sabina Eritja, Núria de Andrea, Carlos Diaz-Martin, Juan Diaz-Lagares, Ángel Jácome, María Amalia Salguero-Aranda, Carmen García Ros, David Davidson, Ben Lopez, Rafel Melero, Ignacio Navarro, Samuel Ramon y Cajal, Santiago de Alava, Enrique Matias-Guiu, Xavier Noguera, Rosa . Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma. Frontiers in Cell and Developmental Biology. 2021, 9:670185, 1-19
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sanegre, Sabina, Lucantoni, Federico, Burgos‐Panadero, Rebeca, Cruz-Merino, Luis de la, Noguera, Rosa, Álvaro Naranjo, Tomás
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
© 2020 by the authors. Tumor progression is mediated by reciprocal interaction between tumor cells and their surrounding tumor microenvironment (TME), which among other factors encompasses the extracellular milieu, immune cells, fibroblasts, and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::b674f4d88a334481c0c482d324cfbd06
http://hdl.handle.net/10261/237696
http://hdl.handle.net/10261/237696
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Giorgia Sonzini, Sofia Granados-Aparici, Sabina Sanegre, Angel Diaz-Lagares, Juan Diaz-Martin, Carlos de Andrea, Núria Eritja, Aida Bao-Caamano, Nicolás Costa-Fraga, David García-Ros, Carmen Salguero-Aranda, Ben Davidson, Rafael López-López, Ignacio Melero, Samuel Navarro, Santiago Ramon y Cajal, Enrique de Alava, Xavier Matias-Guiu, Rosa Noguera
The incidence of new cancer cases is expected to increase significantly in the future, posing a worldwide problem. In this regard, precision oncology and its diagnostic tools are essential for developing personalized cancer treatments. Digital pathol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07ba26f6048f58f12ecfc440c42576d0
http://hdl.handle.net/2445/194054
http://hdl.handle.net/2445/194054
Autor:
Sanegre S; Cancer CIBER (CIBERONC), Madrid, Spain.; Department of Pathology, School of Medical, University of Valencia-INCLIVA, Valencia, Spain., Eritja N; Cancer CIBER (CIBERONC), Madrid, Spain.; Institut de Recerca Biomèdica de LLeida (IRBLLEIDA), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Pathology, Hospital U Arnau de Vilanova and Hospital U de Bellvitge, University of Lleida - University of Barcelona, Barcelona, Spain., de Andrea C; Cancer CIBER (CIBERONC), Madrid, Spain.; Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain., Diaz-Martin J; Cancer CIBER (CIBERONC), Madrid, Spain.; Institute of Biomedicine of Sevilla, Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Diaz-Lagares Á; Cancer CIBER (CIBERONC), Madrid, Spain.; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain., Jácome MA; Department of Mathematics, MODES Group, CITIC, Faculty of Science, Universidade da Coruña, A Coruña, Spain., Salguero-Aranda C; Cancer CIBER (CIBERONC), Madrid, Spain.; Institute of Biomedicine of Sevilla, Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., García Ros D; Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain., Davidson B; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Lopez R; Cancer CIBER (CIBERONC), Madrid, Spain.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain.; Roche-Chus Joint Unit, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), Santiago de Compostela, Spain., Melero I; Cancer CIBER (CIBERONC), Madrid, Spain.; Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain., Navarro S; Cancer CIBER (CIBERONC), Madrid, Spain.; Department of Pathology, School of Medical, University of Valencia-INCLIVA, Valencia, Spain., Ramon Y Cajal S; Cancer CIBER (CIBERONC), Madrid, Spain.; Department of Pathology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain., de Alava E; Cancer CIBER (CIBERONC), Madrid, Spain.; Institute of Biomedicine of Sevilla, Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Matias-Guiu X; Cancer CIBER (CIBERONC), Madrid, Spain.; Institut de Recerca Biomèdica de LLeida (IRBLLEIDA), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Pathology, Hospital U Arnau de Vilanova and Hospital U de Bellvitge, University of Lleida - University of Barcelona, Barcelona, Spain., Noguera R; Cancer CIBER (CIBERONC), Madrid, Spain.; Department of Pathology, School of Medical, University of Valencia-INCLIVA, Valencia, Spain.
Publikováno v:
Frontiers in cell and developmental biology [Front Cell Dev Biol] 2021 Jun 03; Vol. 9, pp. 670185. Date of Electronic Publication: 2021 Jun 03 (Print Publication: 2021).
Autor:
Sanegre S; Department of Pathology, Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, 46010 Valencia, Spain., Lucantoni F; Department of Pathology, Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, 46010 Valencia, Spain., Burgos-Panadero R; Department of Pathology, Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, 46010 Valencia, Spain.; Low Prevalence Tumors, Centro de investigación biomédica en red de cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., de La Cruz-Merino L; Department of Oncology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain., Noguera R; Department of Pathology, Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, 46010 Valencia, Spain.; Low Prevalence Tumors, Centro de investigación biomédica en red de cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Álvaro Naranjo T; Low Prevalence Tumors, Centro de investigación biomédica en red de cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Pathology, Hospital de Tortosa Verge de la Cinta, Catalan Institute of Health, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43500 Tortosa, Spain.; Department of Morphological Science, Medical School, Rovira i Virgili University, 43201 Reus, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Jun 24; Vol. 12 (6). Date of Electronic Publication: 2020 Jun 24.